New York City, NY -- (SBWIRE) -- 01/22/2014 -- To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
StockMarketIntel.com issues a special report on the following stocks: Centrica PLC (ADR) (OTCMKTS:CPYYY), YAHOO JAPAN CORP (OTCMKTS:YAHOY), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), Tokio Marine Holdings Inc (ADR) (OTCMKTS:TKOMY)
Centrica PLC (ADR) (OTCMKTS:CPYYY) gained 0.70% recently, while trading on 53,154 shares at the price of $21.54. If we look at its trading history of the past 52 weeks, the share price suffered a low of $20.76 and was moved to its maximum level of $25.94.The stock changed hands in a range of $21.54 to $21.67, bringing its market capitalization at about $27.17 billion. Centrica plc is an integrated energy company. Company operates in four segments: British Gas, Centrica Energy, Centrica Storage and Direct Energy. The Company has estimated proven and probable (2P) gas and liquids reserves in Europe, North America and Trinidad and Tobago.
For How Long CPYYY will fight for Profitability? Read This Trend Analysis report
YAHOO JAPAN CORP (OTCMKTS:YAHOY) added 1.16% recently, in the current trading session, at $12.20 with a total volume of 49,339 shares. The stock, on average, trades on a volume of 133,602 shares. In the past 52 weeks, the share price has not declined below $6.94 and above $12.76.It floated in a range of $12.18 to $12.25 during the recent trading session, with a beta value of 0.33.Its market capitalization now moved to about $34.68 billion.
For How Long YAHOY Gloss will Attract Investors? Find out via this report
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) recently recorded a gain of 17.35% and was moving within a range of $4.10-$4.68. Its current trading price is $4.68. The share price hit its 52-week low of $0.56 and $4.68 was the best price. The stock completed the day with a total volume of 3.77 million shares, versus an average volume of 2.31 million shares. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10.
Will PVCT Continue To Move Higher? Find Out Here
Tokio Marine Holdings Inc (ADR) (OTCMKTS:TKOMY) declined -0.35% in its current trading activity, bringing its market capitalization around $24.28 billion. The total number of shares that changed hands during the current session up till now was 14,808 shares, as compared to average trading volume of 23,388 shares. The share price after opening at $31.76 made a high of $31.77 and hovered above $31.64, while its recent trading price was $31.65. Tokio Marine Holdings, Inc. is an insurance holding company. Through its subsidiaries and associated companies, the Company operates in four business segments. The Domestic Non-life Insurance segment is engaged in the underwriting of non-life insurance and small amount short term insurance in Japan.
Will TKOMY Bounce Back After yesterday’s Sharp Sell off? Find Out Here
To receive alerts before the crowd, please take 7 seconds to sign up for our Premium SMS Alerts. Grab your cell phone and text the word "PICKS" to "555888”.
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.
Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.
Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)